Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Biosimilar User Fee Act Products; Draft Guidance for Industry

1 organizations filed 1 public comment on Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Biosimilar User Fee Act Products; Draft Guidance for Industry, at the Food and Drug Administration. The comment window closed 1022d ago.

Abstract

OPEN

Commenters (1)

• Association for Accessible Medicinestrade assoc.

  1 filing · confidence 97%